Description

Page Executive
Our client is lean operating biotech innovator focused on in vivo gene editing technology for rare conditions and metabolic diseases. With strong scientific leadership, industry partnerships, and a clear path toward public listing, the company offers a rare opportunity to shape the future of innovative therapeutics. Its growth trajectory, international visibility, and commitment to cutting-edge science make it highly attractive to talent seeking impact, influence, and long-term career acceleration.

Page Executive

• Lead financial strategy, planning, and operations across global entities.
• Drive IPO readiness, including compliance, audit, and capital structure optimisation.
• Build and maintain relationships with investors, analysts, and financial institutions.
• Represent the company at global conferences and investor forums.
• Oversee budgeting, forecasting, and financial reporting.
• Ensure robust financial governance and risk management.

Page Executive

• Proven CFO or senior finance leadership experience in biotech, healthcare, or high-growth sectors.
• Deep understanding of capital markets, IPO processes, and regulatory frameworks (especially HKEX Chapter 18A).
• Strong stakeholder management and communication skills.
• Fluent in English and Mandarin
• Previous experience with innovative biotechnology sector is a must
• Priority will be given to the talents with scientific degree

Page Executive

• Competitive base salary with performance-based incentives.
• Equity participation aligned with IPO milestones.
• Executive-level benefits and relocation support if applicable.